News
PALI
6.08
+2.62%
0.16
ING, PALI and FNCH among pre-market losers
On the Move inG, PALI and FNCH among pre-market losers. Evotec SE (EVO) -31% reports FY results after Q1 earnings release. Enphase Energy (ENPH) buys rest of Greenstone gold mine in $995M cash and stock deal.
Seeking Alpha · 6h ago
Why Nucor Shares Are Trading Lower? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of Nucor Corporation tumbled 6.5% to $179.20 on Tuesday. The company reported worse-than-expected quarterly financial results. Cyngn Inc. Shares jumped 100% after the company was chosen to supply John Deere with industrial automation. Pineapple Energy Inc. And Virgin Galactic Holdings, Inc. Were among the stocks moving in today's mid-day session.
Benzinga · 1d ago
KOPN, BTCM and CETX among mid-day movers
Seeking Alpha · 1d ago
12 Health Care Stocks Moving In Tuesday's Intraday Session
VolitionRX (AMEX:VNRX) shares rose 33.6% to $0.8 during Tuesday's regular session. Palisade Bio (NASDAQ:PALI) stock increased by 29.81% during the session. Kintara Therapeutics and NKGen Biotech were among the losers.
Benzinga · 1d ago
Dow Jumps Over 200 Points; US Services PMI Falls In April
U.S. Stocks traded higher midway through trading on Tuesday. The Dow Jones gained more than 200 points and the NASDAQ rose 1.44%. The S&P Global services PMI fell to 50.9 in April, recording the weakest level in five months. Cyngn Inc. Shares shot up 70% after being selected to supply John Deere's equipment. JetBlue Airways Corporation shares dropped 17% after the company reported first-quarter results.
Benzinga · 1d ago
Why Palisade Bio Stock Is Up Today
Palisade Bio, Inc. Entered into a collaboration with Strand Life Sciences. The company says the collaboration is aimed at advancing precision medicine for ulcerative colitis therapy. PalisadeBio shares have an average 1-year price target of $22.50.
Benzinga · 1d ago
Bio-Path Holdings, Sunshine Biopharma, INVO Bioscience among healthcare movers
Seeking Alpha · 1d ago
US Stocks Higher; PepsiCo Posts Upbeat Earnings
U.S. Stocks traded higher on Tuesday. The Dow traded up 0.23% to 38,328.19 while the NASDAQ rose 0.51%. PepsiCo reported upbeat earnings for its first quarter. In commodity news, oil traded down 0.3% to $81.69 while gold traded down 1.2%. Asian markets closed mostly higher.
Benzinga · 1d ago
Palisade Bio, Strand Life Sciences team up on colitis drug research
Palisade Bio, Strand Life Sciences team up on colitis drug research. Palisade stock shot up 26% in pre-market trading Tuesday. The company announced a strategic collaboration with bioinformatics firm Strand. The partnership will advance precision medicine for the treatment of ulcerative colitis.
Seeking Alpha · 1d ago
PALISADE BIO SHARES RISE 23% PREMARKET AS CO ENTERS INTO A PARTNERSHIP WITH STRAND LIFE SCIENCES
Reuters · 1d ago
PALISADE BIO ENTERS INTO STRATEGIC COLLABORATION WITH STRAND LIFE SCIENCES TO ADVANCE PRECISION MEDICINE APPROACH
Reuters · 1d ago
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Moolec Science stock is rocketing more than 67% on approval for its plant-groan animal proteins. Vaxxinity stock is crashing more than 55% on the company's plans to delist its shares. The biggest pre-market stock movers for Monday morning are earnings, investments, a delisting and more.
Investorplace · 2d ago
Weekly Report: what happened at PALI last week (0415-0419)?
Weekly Report · 2d ago
Analysts’ Opinions Are Mixed on These Healthcare Stocks: SAGE Therapeutics (SAGE) and Palisade Bio (PALI)
TipRanks · 04/17 15:30
Looking Into Palisade Bio's Recent Short Interest
Palisade Bio's short percent of float has risen 756.82% since its last report. The company has 27 thousand shares sold short. Short interest is the number of shares that have been sold short but have not yet been covered. Short selling is when a trader sells shares of a company in the hope that the price will fall.
Benzinga · 04/17 14:45
S&P 500 Edges Lower; PacBio Shares Plunge
U.S. Stocks traded mixed toward the end of trading on Tuesday. The Dow traded up 0.02% to 37,741.96 while the NASDAQ fell 0.20%. The S&P 500 fell around 0.3% in trading. Information technology shares rose by 0.4% on Tuesday while real estate shares fell by 1.8%. Euro zone European shares closed lower on Tuesday; Asian markets closed lower.
Benzinga · 04/16 18:30
Why Skillsoft Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Sk Skillsoft Corp. Shares dipped 26.7% to $6.74 on Tuesday. The company reported mixed fourth-quarter financial results and issued FY25 revenue guidance below estimates. WiSA Technologies, Inc. Shares jumped 85% after the company announced a licensing agreement with an HDTV/PTV brand.
Benzinga · 04/16 18:17
BUZZ-U.S. STOCKS ON THE MOVE-WiSA Technologies, Rivian Automotive, Cigna Group
The Nasdaq and the S&P 500 were muted on Tuesday as higher Treasury yields pressured equities. The blue-chip Dow bucked the trend on robust results from health insurance heavyweight UnitedHealth. The Dow Jones Industrial Average was up 0.13% at 37,783.35. UnitedHealth Group's quarterly results beat expectations.
Reuters · 04/16 17:52
Palisade Bio Is Maintained at Buy by Maxim Group
Dow Jones · 04/16 17:37
Maxim Group Maintains Buy on Palisade Bio, Adjusts Price Target To $22.5 (reverse stock split 1:15)
Benzinga · 04/16 17:27
More
Webull provides a variety of real-time PALI stock news. You can receive the latest news about Palisade Bio Inc through multiple platforms. This information may help you make smarter investment decisions.
About PALI
Palisade Bio, Inc. is a biopharmaceutical company focused on developing therapeutics that protect the integrity of the intestinal barrier. The Company’s approach is founded on the discovery that damage to the intestinal epithelial barrier can result in the leakage of digestive enzymes from the gastrointestinal (GI) tract into the peritoneal cavity, which can damage tissues and promote inflammation, causing a broad array of acute and chronic conditions. Its lead therapeutic candidate, LB1148, is an oral liquid formulation of the well-characterized digestive enzyme inhibitor tranexamic acid (TXA), which is being developed for administration prior to surgeries that are at risk of disrupting the intestinal epithelial barrier. LB1148 is formulated as an aqueous solution for oral (enteral) administration. In addition to TXA, the LB1148 formulation contains polyethylene glycol, carbohydrates, and electrolytes.